Market Overview

Global Crohn's Disease Diagnostic and Therapeutic Market Analysis, Growth, Trends & Forecast 2018-2023 - ResearchAndMarkets.com

Share:

The "Global
Crohn's Disease Diagnostic and Therapeutic Market - Segmented by Type of
Disease, Diagnosis, Treatment, and Geography - Growth, Trends, and
Forecast (2018 - 2023)"
report has been added to ResearchAndMarkets.com's
offering.

The global Crohn's disease diagnostic and therapeutic market is
estimated to grow at a good CAGR during the forecast period.

It is estimated that around 1.6 million Americans have the inflammatory
bowel disease. This number includes about 780,000 of the population who
have Crohn's disease, and another 907,000 people with ulcerative
colitis. Research suggests that about six to 15 new cases of Crohn's
disease are diagnosed per 100,000 people each year. People are most
frequently diagnosed with Crohn's disease and ulcerative colitis in the
late adolescence or in early adulthood, even though the diagnosis may
happen at any age.

Current costs for the treatment and diagnosis of Crohn's disease is
high, due to the availability of several new therapeutic drugs and
changes in the surgical treatment of the disease. For example, the total
cost of Crohn's disease in the United States is around USD 3.6 billion
every year, and the average yearly medical cost per patient is about USD
8,265, with more than one-third of that cost being medications. Biologic
medications or drugs are usually expensive. Hospitalization accounted
for 31.4% of the cost. On an average, people who have to be hospitalized
for Crohn's disease are expected to spend about 5.8 days in the hospital.

North America is dominating the Crohn's disease diagnostic and
therapeutic market due to the increasing prevalence of Crohn's disease
in the region. Asia-Pacific is expected to record a substantial growth
in the forecast period.

Companies Mentioned

  • Abbvie
  • Celgene Corporation
  • Genentech
  • Janssen Biotech Inc.
  • Pfizer Inc.
  • Prometheus Laboratories Inc.
  • Salix Pharmaceuticals Inc.
  • Takeda's Pharmaceutical Ltd
  • Johnson & Johnson

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

11. Disclaimer

For more information about this report visit https://www.researchandmarkets.com/research/mpmfbx/global_crohns?w=4

View Comments and Join the Discussion!